Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system

  1. Fabrice Jean-Pierre  Is a corresponding author
  2. Thomas H Hampton
  3. Daniel Schultz
  4. Deborah A Hogan
  5. Marie-Christine Groleau
  6. Eric Déziel
  7. George A O'Toole  Is a corresponding author
  1. Geisel School of Medicine at Dartmouth, United States
  2. Dartmouth College, United States
  3. Institut National de la Recherche Scientifique, Canada

Abstract

Interspecies interactions can drive the emergence of unexpected microbial phenotypes that are not observed when studying monocultures. The cystic fibrosis (CF) lung consists of a complex environment where microbes, living as polymicrobial biofilm-like communities, are associated with negative clinical outcomes for persons with CF (pwCF). However, the current lack of in vitro models integrating the microbial diversity observed in the CF airway hampers our understanding of why polymicrobial communities are recalcitrant to therapy in this disease. Here, integrating computational approaches informed by clinical data, we built a mixed community of clinical relevance to the CF lung composed of Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus sanguinis and Prevotella melaninogenica. We developed and validated this model biofilm community with multiple isolates of these four genera. When challenged with tobramycin, a front-line antimicrobial used to treat pwCF, the microorganisms in the polymicrobial community show altered sensitivity to this antibiotic compared to monospecies biofilms. We observed that wild-type P. aeruginosa is sensitized to tobramycin in a mixed community versus monoculture, and this observation holds across a range of community relative abundances. We also report that LasR loss-of-function, a variant frequently detected in the CF airway, drives tolerance of P. aeruginosa to tobramycin specifically in the mixed community. Our data suggest that the molecular basis of this community-specific recalcitrance to tobramycin for the P. aeruginosa LasR mutant is increased production of phenazines. Our work support the importance of studying a clinically-relevant model polymicrobial biofilms to understand community-specific traits relevant to infections.

Data availability

Figure 1 - figure supplement 3 & Source Data 1 contains the numerical data used to generate the figure.Figure 1 - figure supplement 4 & Source Data 2 contains numerical data used to generate the figure.Source Code 1 contains the script used to generate Figure 1, Figure 1 - figure supplement 1 and Figure 1 - figure supplement 4.Source Code 2 contains the script used to generate the modeling data presented Figure 1 - figure supplement 1.

The following previously published data sets were used

Article and author information

Author details

  1. Fabrice Jean-Pierre

    Geisel School of Medicine at Dartmouth, Hanover, United States
    For correspondence
    jeanpierre.fabrice@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3056-8356
  2. Thomas H Hampton

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Daniel Schultz

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Deborah A Hogan

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Marie-Christine Groleau

    Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Eric Déziel

    Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. George A O'Toole

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    For correspondence
    georgeo@dartmouth.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2861-4392

Funding

Cystic Fibrosis Foundation (JEAN21F0)

  • Fabrice Jean-Pierre

National Institutes of Health (R01 AI155424)

  • George A O'Toole

Canadian Institutes of Health Research (MOP-142466)

  • Eric Déziel

National Institutes of Health (5 P20 GM130454)

  • Daniel Schultz

Cystic Fibrosis Foundation (HOGAN19G0)

  • Deborah A Hogan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Jean-Pierre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,229
    views
  • 424
    downloads
  • 29
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fabrice Jean-Pierre
  2. Thomas H Hampton
  3. Daniel Schultz
  4. Deborah A Hogan
  5. Marie-Christine Groleau
  6. Eric Déziel
  7. George A O'Toole
(2023)
Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system
eLife 12:e81604.
https://doi.org/10.7554/eLife.81604

Share this article

https://doi.org/10.7554/eLife.81604

Further reading

    1. Microbiology and Infectious Disease
    Xin Ma, Meng Li ... Xinyan Han
    Research Article

    As the largest mucosal surface, the gut has built a physical, chemical, microbial, and immune barrier to protect the body against pathogen invasion. The disturbance of gut microbiota aggravates pathogenic bacteria invasion and gut barrier injury. Fecal microbiota transplantation (FMT) is a promising treatment for microbiome-related disorders, where beneficial strain engraftment is a significant factor influencing FMT outcomes. The aim of this research was to explore the effect of FMT on antibiotic-induced microbiome-disordered (AIMD) models infected with enterotoxigenic Escherichia coli (ETEC). We used piglet, mouse, and intestinal organoid models to explore the protective effects and mechanisms of FMT on ETEC infection. The results showed that FMT regulated gut microbiota and enhanced the protection of AIMD piglets against ETEC K88 challenge, as demonstrated by reduced intestinal pathogen colonization and alleviated gut barrier injury. Akkermansia muciniphila (A. muciniphila) and Bacteroides fragilis (B. fragilis) were identified as two strains that may play key roles in FMT. We further investigated the alleviatory effects of these two strains on ETEC infection in the AIMD mice model, which revealed that A. muciniphila and B. fragilis relieved ETEC-induced intestinal inflammation by maintaining the proportion of Treg/Th17 cells and epithelial damage by moderately activating the Wnt/β-catenin signaling pathway, while the effect of A. muciniphila was better than B. fragilis. We, therefore, identified whether A. muciniphila protected against ETEC infection using basal-out and apical-out intestinal organoid models. A. muciniphila did protect the intestinal stem cells and stimulate the proliferation and differentiation of intestinal epithelium, and the protective effects of A. muciniphila were reversed by Wnt inhibitor. FMT alleviated ETEC-induced gut barrier injury and intestinal inflammation in the AIMD model. A. muciniphila was identified as a key strain in FMT to promote the proliferation and differentiation of intestinal stem cells by mediating the Wnt/β-catenin signaling pathway.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.